000 01262 a2200385 4500
005 20250512043631.0
264 0 _c19890421
008 198904s 0 0 eng d
022 _a0040-6376
024 7 _a10.1136/thx.43.12.992
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLyons, D J
245 0 0 _aDefective cell mediated immunity in sarcoidosis: effect of interleukin-2.
_h[electronic resource]
260 _bThorax
_cDec 1988
300 _a992-7 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aCell Division
_xdrug effects
650 0 4 _aCytotoxicity, Immunologic
_xdrug effects
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aImmunity, Cellular
650 0 4 _aIn Vitro Techniques
650 0 4 _aInterleukin-2
_xtherapeutic use
650 0 4 _aLeukocytes, Mononuclear
_xdrug effects
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aRecombinant Proteins
_xtherapeutic use
650 0 4 _aSarcoidosis
_ximmunology
700 1 _aGao, L
700 1 _aMitchell, E B
700 1 _aMitchell, D N
773 0 _tThorax
_gvol. 43
_gno. 12
_gp. 992-7
856 4 0 _uhttps://doi.org/10.1136/thx.43.12.992
_zAvailable from publisher's website
999 _c3272147
_d3272147